New Horizon Health (FRA:6YZ) Piotroski F-Score: 0 (As of Jul. 23, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:6YZ New Horizon Health Ltd FRA:6YZ
35 GF Score
Price €1.62
View Full Analysis

What is New Horizon Health Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

New Horizon Health has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for New Horizon Health's Piotroski F-Score or its related term are showing as below:

New Horizon Health  (FRA:6YZ) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


New Horizon Health Piotroski F-Score Related Terms


New Horizon Health Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for New Horizon Health's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

New Horizon Health Piotroski F-Score Chart

New Horizon Health Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22
Piotroski F-Score
N/A N/A 3.00 6.00 3.00

New Horizon Health Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only N/A 6.00 4.00 3.00 0.00
FRA:6YZ
35GF Score
New Horizon Health Ltd FRA:6YZ
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec22) TTM:Last Year (Dec21) TTM:
Net Income was €-10.7 Mil.
Cash Flow from Operations was €-55.9 Mil.
Revenue was €103.6 Mil.
Gross Profit was €87.5 Mil.
Average Total Assets from the begining of this year (Dec21)
to the end of this year (Dec22) was (327.065 + 348.643) / 2 = €337.854 Mil.
Total Assets at the begining of this year (Dec21) was €327.1 Mil.
Long-Term Debt & Capital Lease Obligation was €30.5 Mil.
Total Current Assets was €270.9 Mil.
Total Current Liabilities was €30.8 Mil.
Net Income was €-428.7 Mil.

Revenue was €29.6 Mil.
Gross Profit was €21.5 Mil.
Average Total Assets from the begining of last year (Dec20)
to the end of last year (Dec21) was (102.829 + 327.065) / 2 = €214.947 Mil.
Total Assets at the begining of last year (Dec20) was €102.8 Mil.
Long-Term Debt & Capital Lease Obligation was €4.5 Mil.
Total Current Assets was €286.1 Mil.
Total Current Liabilities was €26.9 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

New Horizon Health's current Net Income (TTM) was -10.7. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

New Horizon Health's current Cash Flow from Operations (TTM) was -55.9. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec21)
=-10.729/327.065
=-0.03280388

ROA (Last Year)=Net Income/Total Assets (Dec20)
=-428.701/102.829
=-4.16906709

New Horizon Health's return on assets of this year was -0.03280388. New Horizon Health's return on assets of last year was -4.16906709. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

New Horizon Health's current Net Income (TTM) was -10.7. New Horizon Health's current Cash Flow from Operations (TTM) was -55.9. ==> -55.9 <= -10.7 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec21 to Dec22
=30.485/337.854
=0.09023128

Gearing (Last Year: Dec21)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec20 to Dec21
=4.489/214.947
=0.02088422

New Horizon Health's gearing of this year was 0.09023128. New Horizon Health's gearing of last year was 0.02088422. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec22)=Total Current Assets/Total Current Liabilities
=270.887/30.795
=8.79646046

Current Ratio (Last Year: Dec21)=Total Current Assets/Total Current Liabilities
=286.112/26.867
=10.6491979

New Horizon Health's current ratio of this year was 8.79646046. New Horizon Health's current ratio of last year was 10.6491979. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

New Horizon Health's number of shares in issue this year was 422.929. New Horizon Health's number of shares in issue last year was 378.499. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=87.494/103.579
=0.8447079

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=21.488/29.563
=0.72685451

New Horizon Health's gross margin of this year was 0.8447079. New Horizon Health's gross margin of last year was 0.72685451. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec21)
=103.579/327.065
=0.3166924

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec20)
=29.563/102.829
=0.28749672

New Horizon Health's asset turnover of this year was 0.3166924. New Horizon Health's asset turnover of last year was 0.28749672. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+1+0+0+0+0+1+1
=3

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

New Horizon Health has an F-score of 3. It is a bad or low score, which usually implies poor business operation.


New Horizon Health Business Description

Address 400 Jiang’er Road, 13th Floor, T1 Building, Binjiang District, Zhejiang, Hangzhou, CHN, 310052
New Horizon Health Ltd is engaged in early cancer screening and in-home testing in China. The company has an early detection and cancer screening-focused pipeline of five products and product candidates with an emphasis on colorectal cancer screening. The company focuses on cancer prevention and cure through screening and early detection. It generates maximum revenue from ColoClear and Pupu Tube products.
35GF Score

Get the complete analysis for FRA:6YZ

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.62
Price